C07C 233/77
Having the nitrogen atom of at least one of the carboxamide groups
Official title: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
C07C233/77 (Having the nitrogen atom of at least one of the carboxamide groups) appears on 397 US grants and 400 published applications in this corpus.
Search patents in C07C- Granted patents
- 397
- Published applications
- 400
- Assignees
- 287
- Inventors
- 1,426
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 5 | 0 |
| 1991 | 3 | 0 |
| 1992 | 6 | 0 |
| 1993 | 4 | 0 |
| 1994 | 9 | 0 |
| 1995 | 5 | 0 |
| 1996 | 9 | 0 |
| 1997 | 8 | 0 |
| 1998 | 11 | 0 |
| 1999 | 9 | 0 |
| 2000 | 4 | 0 |
| 2001 | 12 | 2 |
| 2002 | 19 | 22 |
| 2003 | 9 | 20 |
| 2004 | 21 | 32 |
| 2005 | 8 | 13 |
| 2006 | 15 | 18 |
| 2007 | 22 | 22 |
| 2008 | 9 | 22 |
| 2009 | 11 | 10 |
| 2010 | 15 | 18 |
| 2011 | 7 | 7 |
| 2012 | 11 | 13 |
| 2013 | 11 | 15 |
| 2014 | 18 | 20 |
| 2015 | 11 | 15 |
| 2016 | 14 | 23 |
| 2017 | 17 | 24 |
| 2018 | 12 | 11 |
| 2019 | 11 | 13 |
| 2020 | 14 | 21 |
| 2021 | 11 | 15 |
| 2022 | 13 | 12 |
| 2023 | 10 | 12 |
| 2024 | 10 | 14 |
| 2025 | 5 | 5 |
| 2026 | 3 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cyclopropylamide compounds against parasites in fish16 Jun 2026US 12,655,090 B2Intervet Inc.
- Small-cell polystyrene foams, and process for producing same19 May 2026US 12,630,693 B2Ineos Styrolution Group GmbH
- Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof14 Apr 2026US 12,599,599 B2Medicon Pharmaceuticals, Inc.
- Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof7 Oct 2025US 12,435,051 B2Vivozon Inc.
- Diarylamide compound and application thereof30 Sep 2025US 12,428,389 B2Sunshine Lake Pharma Co., Ltd.
- Aromatic compounds for use as protein phosphatase 2a (pp2a) modulators10 Sep 2026US 2026/0265190 A1Rappta Therapeutics Oy
- Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase25 Sep 2025US 2025/0296935 A1Celltaxis, LLC
- Ketone inhibitors of lysine gingipain28 Aug 2025US 2025/0270162 A1Lighthouse Pharmaceuticals, Inc.
- Inducers of integrated stress response to treat cancer14 Aug 2025US 2025/0257041 A1Board of Regents, The University of Texas System
- Bicyclic cx3cr1 receptor agonists14 Aug 2025US 2025/0257057 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Dense star polymers having core, core branches, terminal groups293US 4,507,466 AThe Dow Chemical Company · 1985
- Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method125US 5,760,246 A1998
- Cell differentiation inducer110US 6,174,905 B1Mitsui Chemicals, Inc. · 2001
- Substituted aminomethyltetralins and their heterocyclic analogues81US 5,137,901 ABayer Aktiengesellschaft · 1992
- Inhibitors of histone deacetylase67US 6,897,220 B2MethylGene Inc. · 2005